Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID4441 | AYDFYPGKIDV | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4460 | CLAYDFYPGKIDVHWT | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4722 | EDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4723 | EDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4724 | EDVPAFQALGSLNDLQFFRYNS | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4726 | EFNKEIPAWVPFDPA | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4727 | EFNKEIPAWVPFDPAAQI | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4728 | EFNKEIPAWVPFDPAAQIT | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5001 | FQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5221 | GLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5222 | GLSKHVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5402 | HVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5565 | IYTGLSKHVEDVPAFQALGSLNDL | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5566 | IYTGLSKHVEDVPAFQALGSLNDLQ | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5567 | IYTGLSKHVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5711 | LAYDFYPGKIDV | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6510 | QENQDGRYSLT | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6511 | QENQDGRYSLTY | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6512 | QENQDGRYSLTYIYT | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6513 | QENQDGRYSLTYIYTGL | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6514 | QENQDGRYSLTYIYTGLSKHV | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6766 | SCHVQHSSLAQPLVVPWEAS | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6956 | SLAQPLVVPWEAS | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7404 | TGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7687 | TYIYTGLSKHVEDVPAFQALGSLND | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7688 | TYIYTGLSKHVEDVPAFQALGSLNDL | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7689 | TYIYTGLSKHVEDVPAFQALGSLNDLQ | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7690 | TYIYTGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7691 | TYIYTGLSKHVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7776 | VEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7777 | VEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID7971 | VPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8196 | WVPFDPAAQI | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8197 | WVPFDPAAQIT | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8244 | YDFYPGKIDV | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8287 | YIYTGLSKHVEDVPAFQA | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8288 | YIYTGLSKHVEDVPAFQALGSLNDL | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8289 | YIYTGLSKHVEDVPAFQALGSLNDLQ | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8290 | YIYTGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8291 | YIYTGLSKHVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8384 | YTGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8385 | YTGLSKHVEDVPAFQALGSLNDLQFF | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8395 | YVQRAKAYLEEECPA | Zinc-alpha-2-glycoprotein | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID9955 | QKAREDIF | Zinc-alpha-2-glycoprotein | Urine | 1006.5155 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID9995 | ITKQKWEAE | Zinc-alpha-2-glycoprotein | Urine | 1132.591 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10005 | WRQVEGMED | Zinc-alpha-2-glycoprotein | Urine | 1149.4816 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10040 | WKYYYDGKD | Zinc-alpha-2-glycoprotein | Urine | 1237.5395 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10118 | RKYLKYSKNIL | Zinc-alpha-2-glycoprotein | Urine | 1425.8143 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10131 | SKHVEDVPAFQAL | Zinc-alpha-2-glycoprotein | Urine | 1440.7117 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10160 | ITKQKWEAEPVY | Zinc-alpha-2-glycoprotein | Urine | 1491.78 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10173 | WKQDSQLQKARE | Zinc-alpha-2-glycoprotein | Urine | 1516.7791 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10232 | YPGKIDVHWTRAGE | Zinc-alpha-2-glycoprotein | Urine | 1628.8094 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10265 | NKEIPAWVPFDPAAQ | Zinc-alpha-2-glycoprotein | Urine | 1682.8493 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10290 | WKQDSQLQKAREDI | Zinc-alpha-2-glycoprotein | Urine | 1744.9057 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10337 | FRYNSKDRKSQPMGL | Zinc-alpha-2-glycoprotein | Urine | 1826.9887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10367 | WKQDSQLQKAREDIF | Zinc-alpha-2-glycoprotein | Urine | 1891.9692 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10414 | YPGKIDVHWTRAGEVQE | Zinc-alpha-2-glycoprotein | Urine | 1984.9602 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10583 | IYTGLSKHVEDVPAFQALGSLND | Zinc-alpha-2-glycoprotein | Urine | 2474.2609 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10657 | IYTGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | 2862.4487 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID11078 | NA | ZA2G_HUMAN | Urine | 1825.638 | MALDI-TOF | Clear cell renal carcinoma | "Differentially expression in control vs ccRCC cancer, Primary Tumor or grade" | 26482227 |